Restoration Robotics Receives FDA Clearance

Restoration Robotics™ Receives US FDA 510(k) Clearance for Implantation Function

Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, announced today that the Company has received US FDA 510(k) clearance to expand the ARTAS® technology to include implantation.  The Company plans to begin offering this additional functionality before the end of 2018.

Ryan Rhodes, President and Chief Executive Officer of Restoration Robotics said, “510(k) clearance of the implantation technology enables an important addition to our already-robust hair restoration solution.

We plan to complete the necessary design and engineering work to launch the implantation functionality by year-end.

This enhancement will further extend ARTAS’ leadership position in the field of robotic hair restoration.”

a world leader in Hair Transplant technology, Hair Restoration surgery and Hair Transplant clinical research as well as inventing ARTAS® Robotic Hair Transplant technologiesAbout Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS Robotic Hair Restoration System.

We believe the ARTAS System is the first and only physician-assisted system to dissect, and assist in the harvesting of, follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.

Source

Posted in: